13 results
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Pain Assessment ... Management #Pain ... #Pharmacology # ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... #Management # ... Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... (PAMI) - Muscle ... Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
(PAMI) - Neuropathic ... Pain Medications ... #Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... (PAMI) - Nerve ... #Pain #Pharmacology ... Nerve #Blocks #Medications ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... (PAMI) - Intranasal ... #Management # ... Pain #Pharmacology ... #Table #PAMI
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... medications, with ... kidney), which causes ... #Pharmacology # ... Medications #DM2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... #Mellitus #DM2 ... #pharmacology # ... comparison #table
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology ... Toxicities: • Joint pains ... not definitively cause ... #Pharmacology # ... Summary #DM2 #diabetes
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... very tolerable medication ... #Renal #Dosing ... #Pharmacology #Management ... #Diabetes #DM2